The CRISPR/Cas9 system targeting EGFR exon 17 abrogates NF-κB activation via epigenetic modulation of UBXN1 in EGFRwt/vIII glioma cells

Autor: Huang, Kai, Yang, Chao, Wang, Qi-xue, Li, Yan-sheng, Fang, Chuan, Tan, Yan-li, Wei, Jian-wei, Wang, Yun-fei, Li, Xin, Zhou, Jun-hu, Zhou, Bing-cong, Yi, Kai-kai, Zhang, Kai-liang, Li, Jie, Kang, Chun-sheng
Zdroj: In Cancer Letters 1 March 2017 388:269-280
Databáze: ScienceDirect
Externí odkaz: